From: Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan
Treatment
Total
Incremental
ICER (Cost/QALY)
Costs (Yen)
QALYs
MEPM
2,530,568.97
2.18
CTZ/TAZ
2,955,300.18
2.35
424,731.22
0.17
2,548,738